Interferon for Treatment: the Dust Settles

Overview

Journal Br Med J (Clin Res Ed)

Specialty General Medicine

Date 1988 Jun 4

PMID 2456124

Citations 4

Authors

D Galvani

S D Griffiths

J C Cawley

Affiliations

Soon will be listed here.

Citing Articles

Type I interferon and interferon-stimulated gene expression in oral epithelial cells.

Brice D, Figgins E, Yu F, Diamond G Mol Oral Microbiol. 2019; 34(6):245-253.

PMID: 31520463 PMC: 7362904. DOI: 10.1111/omi.12270.

Clinical decisions in the management of the cardiomyopathies.

Goodwin J Drugs. 1989; 38(6):988-99.

PMID: 2693049 DOI: 10.2165/00003495-198938060-00009.

Cytokines: biological function and clinical use.

Galvani D J R Coll Physicians Lond. 1988; 22(4):226-31.

PMID: 2466118 PMC: 5379271.

Recombinant human interferon gamma in the treatment of rheumatoid arthritis: double blind placebo controlled study.

Machold K, Neumann K, Smolen J Ann Rheum Dis. 1992; 51(9):1039-43.

PMID: 1417133 PMC: 1004833. DOI: 10.1136/ard.51.9.1039.

References

Sreevalsan T, Rozengurt E, Taylor-Papadimitriou J, Burchell J . Differential effect of interferon on DNA synthesis, 2-deoxyglucose uptake and ornithine decarboxylase activity in 3T3 cells stimulated by polypeptide growth factors and tumor promotors. J Cell Physiol. 1980; 104(1):1-9. DOI: 10.1002/jcp.1041040102. View

ikic D, Krusic J, KIRHMAJER V, Knezevic M, Maricic Z, Rode B . Application of human leucocyte interferon in patients with carcinoma of the uterine cervix. Lancet. 1981; 1(8228):1027-30. DOI: 10.1016/s0140-6736(81)92190-5. View

Strander H, Aparisi T, Blomgren H, Brostrom L, Cantell K, EINHORN S . Adjuvant interferon treatment of human osteosarcoma. Recent Results Cancer Res. 1982; 80:103-7. DOI: 10.1007/978-3-642-81685-7_17. View

Kimchi A . Increased levels of interferon-induced (2'--5') oligo-isoadenylate synthetase in mature T-lymphocytes and in differentiated Friend-erythroleukemic cells. J Interferon Res. 1981; 1(4):559-69. DOI: 10.1089/jir.1981.1.559. View

Sherwin S, Knost J, Fein S, Abrams P, Foon K, Ochs J . A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients. JAMA. 1982; 248(19):2461-6. View

McCabe B, Clark K . Interferon and laryngeal papillomatosis. The Iowa experience. Ann Otol Rhinol Laryngol. 1983; 92(1 Pt 1):2-7. DOI: 10.1177/000348948309200102. View

Broxmeyer H, Lu L, PLATZER E, Feit C, Juliano L, Rubin B . Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol. 1983; 131(3):1300-5. View

Quesada J, Reuben J, Manning J, Hersh E, Gutterman J . Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med. 1984; 310(1):15-8. DOI: 10.1056/NEJM198401053100104. View

Ernstoff M, Kirkwood J . Changes in the bone marrow of cancer patients treated with recombinant interferon alpha-2. Am J Med. 1984; 76(4):593-6. DOI: 10.1016/0002-9343(84)90282-1. View

10.

Ahre A, Bjorkholm M, Mellstedt H, Brenning G, ENGSTEDT L, Gahrton G . Human leukocyte interferon and intermittent high-dose melphalan-prednisone administration in the treatment of multiple myeloma: a randomized clinical trial from the Myeloma Group of Central Sweden. Cancer Treat Rep. 1984; 68(11):1331-8. View

11.

Einat M, Resnitzky D, Kimchi A . Close link between reduction of c-myc expression by interferon and, G0/G1 arrest. Nature. 1985; 313(6003):597-600. DOI: 10.1038/313597a0. View

12.

Foon K, Bottino G, Abrams P, Fer M, Longo D, Schoenberger C . Phase II trial of recombinant leukocyte A interferon in patients with advanced chronic lymphocytic leukemia. Am J Med. 1985; 78(2):216-20. DOI: 10.1016/0002-9343(85)90429-2. View

13.

COSTANZI J, Cooper M, Scarffe J, Ozer H, Grubbs S, FERRARESI R . Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma. J Clin Oncol. 1985; 3(5):654-9. DOI: 10.1200/JCO.1985.3.5.654. View

14.

Kirkwood J, Ernstoff M, Davis C, Reiss M, Ferraresi R, Rudnick S . Comparison of intramuscular and intravenous recombinant alpha-2 interferon in melanoma and other cancers. Ann Intern Med. 1985; 103(1):32-6. DOI: 10.7326/0003-4819-103-1-32. View

15.

De Maeyer-Guignard J, De Maeyer E . Immunomodulation by interferons: recent developments. Interferon. 1985; 6:69-91. View

16.

Worman C, Catovsky D, Bevan P, Camba L, Joyner M, Green P . Interferon is effective in hairy-cell leukaemia. Br J Haematol. 1985; 60(4):759-63. DOI: 10.1111/j.1365-2141.1985.tb07480.x. View

17.

Dooley J, Davis G, Peters M, WAGGONER J, Goodman Z, Hoofnagle J . Pilot study of recombinant human alpha-interferon for chronic type B hepatitis. Gastroenterology. 1986; 90(1):150-7. DOI: 10.1016/0016-5085(86)90087-9. View

18.

DOUGLAS Jr R . The common cold--relief at last?. N Engl J Med. 1986; 314(2):114-5. DOI: 10.1056/NEJM198601093140209. View

19.

Oconnell M, Colgan J, Oken M, RITTS Jr R, Kay N, Itri L . Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study. J Clin Oncol. 1986; 4(2):128-36. DOI: 10.1200/JCO.1986.4.2.128. View

20.

Vadhan-Raj S, Al-Katib A, Bhalla R, Pelus L, Nathan C, Sherwin S . Phase I trial of recombinant interferon gamma in cancer patients. J Clin Oncol. 1986; 4(2):137-46. DOI: 10.1200/JCO.1986.4.2.137. View